Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-25-004213
Filing Date
2025-01-30
Accepted
2025-01-30 08:01:24
Documents
94

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 3176764
2 ex4-14.htm EX-4.14 124076
3 ex4-15.htm EX-4.15 134199
4 ex4-16.htm EX-4.16 131751
5 ex4-17.htm EX-4.17 136164
6 ex5-1.htm EX-5.1 24504
7 ex10-33.htm EX-10.33 262891
8 ex23-2.htm EX-23.2 4167
9 ex107.htm EX-FILING FEES 59771
10 ex5-1_001.jpg GRAPHIC 14125
11 ex5-1_002.jpg GRAPHIC 59111
  Complete submission text file 0001493152-25-004213.txt   13400721

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE envb-20240930.xsd EX-101.SCH 81531
13 XBRL CALCULATION FILE envb-20240930_cal.xml EX-101.CAL 81921
14 XBRL DEFINITION FILE envb-20240930_def.xml EX-101.DEF 337008
15 XBRL LABEL FILE envb-20240930_lab.xml EX-101.LAB 631302
16 XBRL PRESENTATION FILE envb-20240930_pre.xml EX-101.PRE 487974
97 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 2108261
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-284277 | Film No.: 25571216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)